Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

EFFECT OF CURCUMIN IN CELECOXIB AND STREPTOZOTOCIN INDUCED EXPERIMENTAL DEMENTIA OF ALZHEIMER`S DISEASE IN MICE

Divya Pathak*, Harlokesh Narayan Yadav, Jeetendra Kumar Gupta

Institute of Pharmaceutical Research, GLA, University, Mathura (U.P)

ABSTRACT

To investigate the effect of Curcumin in Celecoxib and STZ induced experimental dementia of Alzheimer disease in mice. Celecoxib and STZ for administrations were used to induce experimental dementia. Curcumin (150 mg/kg, p.o) treatment started two days prior to Celecoxib or STZ administration followed by treatment of Celecoxib (100mg/kg, p.o) and STZ (3mg/kg, i.c.v). Cognitive behaviour was asses by using Morris water maze and elevated plus-maze was used for by measuring transfer latency (TL). On 9th day animals were sacrificed and acetyl cholinesterase activity was measured to assess cholinergic activity of the brain,thiobarbituric acid reactive species (TBARS) levels, catalase activity, DPPH assay and reduced glutathione (GSH) levels were measured to asses the oxidative stress in brain. The present data demonstrate that curcumin improves memory in celecoxib or STZ induced dementia. From the present data it may be concluded improvement of memory by treatment of Curcumin is due to decrease the oxidative stress.

Keywords: Morris water maze, elevate plus maze, oxidative stress, acetyl-cholinesterase activity, TBARS, DPPH, GSH, Alzheimer`s disease.


[Full Text Article]